OUTSOURCED PHARMA

During my discussion with two executive members of the relatively new Society For RNA Therapeutics (SRT) they mentioned external partners and...

The FDA informed us again in April that the Bloomington, Indiana, facilities owned by Catalent until sold to Novo Nordisk in December 2024, has...

Allogeneic cell therapy is often discussed as though it were a single modality moving along a single development path. That framing is...

Antibody-oligonucleotide conjugates (AOCs) combine the targeting precision of antibodies with the gene-modulating power of oligonucleotides,...

A vote for now-President Joe Biden was a vote to give your IP away. Feigned surprise at Biden’s agreement with the World Trade Organization...

Did the U.S. government just seize a private CDMO’s operations? There are serious, extenuating circumstances no doubt, but we need a deeper...

By Kalah Auchincloss, SVP & deputy general counsel, Greenleaf Health, Inc. Almost exactly one year ago, in March 2020, the U.S. FDA announced...

Jubilant Life Sciences Ltd (“Jubilant”), an integrated global Pharmaceuticals and Life Sciences Company, recently announced that its...

Agreement to perform fill/finish services for approximately 60–90 million doses in the U.S. this year Manufacturing will take place at Baxter...

Many organic solvents are used during the manufacturing of active pharmaceutical ingredients (APIs) and associated intermediates. Solvents may...